Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cellsToshihiro Nagato, Hiroya Kobayashi, Mitsuru Yanai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2002
Identification of an antigenic epitope for helper T lymphocytes from carcinoembryonic antigenHiroya Kobayashi, Ryusuke Omiya, Marta Ruiz, et al.
Cancer Immunology, Immunotherapy : CII|March 1, 2017
Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor siteTakayuki Ohkuri, Akemi Kosaka, Kei Ishibashi, et al.
Biochemical and Biophysical Research Communications|June 19, 2017
Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAbJiro Uehara, Takayuki Ohkuri, Akemi Kosaka, et al.
Japanese Journal of Ophthalmology|September 27, 2015
Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injuryAkito Shimouchi, Harumasa Yokota, Shinji Ono, et al.
Biochemical and Biophysical Research Communications|November 28, 2019
Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinomaShohei Harabuchi, Akemi Kosaka, Yuki Yajima, et al.
Cancer Science|May 17, 2022
A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicityYuki Yajima, Akemi Kosaka, Kei Ishibashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2005
Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patientsToshihiro Nagato, Hiroya Kobayashi, Kan Kishibe, et al.
The American Journal of Pathology|March 26, 2003
Modulation of hepatic granulomatous responses by transgene expression of DAP12 or TREM-1-Ig moleculesHitoshi Nochi, Naoko Aoki, Kensuke Oikawa, et al.
Cancer Science|October 26, 2022
Mitogen-activated protein kinase inhibition augments the T cell response against HOXB7-expressing tumor through human leukocyte antigen upregulationHiroki Komatsuda, Risa Wakisaka, Michihisa Kono, et al.
Pageof 10